Standard BioTools Inc.

Historical 13F Holders

Symbol
LAB
CUSIP
34385P108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 34385P108 since 12/18/2024, largest first.

Filer % of Class Filed
Casdin Capital, LLC 13D/A
23.9% 6/9/2026
Event 6/6/2026
Viking Global Investors LP 13D
15.0% 6/12/2026
Event 6/6/2026
Mak Capital One LLC 13G/A
7.3% 8/14/2026
Event 6/30/2026
MAK Capital Fund LP 13G/A
6.7% 5/15/2026
Event 3/31/2026
Long Focus Capital Management, LLC 13G
6.0% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
BlackRock, Inc. 13G/A 2.0% 7/30/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 18.1 k $13.4 k
2026 Q2 147 296 M $244 M
2026 Q1 158 297 M $273 M
2025 Q4 165 303 M $387 M
2025 Q3 160 286 M $372 M
2025 Q2 164 281 M $337 M
2025 Q1 150 285 M $308 M
2024 Q4 148 278 M $487 M
2024 Q3 146 281 M $543 M
2024 Q2 153 284 M $503 M
2024 Q1 153 281 M $762 M
2023 Q4 92 52.8 M $117 M
2023 Q3 76 47.4 M $138 M
2023 Q2 69 46.2 M $89.1 M
2023 Q1 73 46.1 M $89.9 M
2022 Q4 74 46.8 M $54.7 M
2022 Q3 70 38.6 M $42.5 M
2022 Q2 94 43.9 M $70.2 M
2022 Q1 121 50.0 M $180 M
2021 Q4 140 56.5 M $221 M
2021 Q3 135 58.6 M $387 M
2021 Q2 122 57.6 M $354 M
2021 Q1 154 59.4 M $269 M
2020 Q4 164 66.4 M $398 M
2020 Q3 149 66.9 M $501 M
2020 Q2 119 62.8 M $252 M
2020 Q1 108 64.1 M $163 M
2019 Q4 103 65.0 M $226 M
2019 Q3 131 63.9 M $296 M
2019 Q2 142 70.8 M $872 M
2019 Q1 137 64.7 M $860 M
2018 Q4 104 49.9 M $430 M
2018 Q3 91 39.3 M $294 M
2018 Q2 88 38.2 M $227 M
2018 Q1 89 37.1 M $217 M
2017 Q4 85 36.7 M $217 M
2017 Q3 85 36.2 M $182 M
2017 Q2 84 26.3 M $106 M
2017 Q1 86 27.2 M $155 M
2016 Q4 88 27.0 M $196 M
2016 Q3 101 27.2 M $218 M
2016 Q2 106 27.3 M $246 M
2016 Q1 109 28.5 M $230 M
2015 Q4 122 28.5 M $308 M
2015 Q3 122 31.1 M $252 M
2015 Q2 116 31.0 M $750 M
2015 Q1 110 30.6 M $1.29 B
2014 Q4 109 30.5 M $1.03 B
2014 Q3 112 28.7 M $702 M
2014 Q2 116 27.6 M $811 M
2014 Q1 119 26.2 M $1.15 B